CES 2024: XENCO MEDICAL UNVEILS BREAKTHROUGH CONVERGENCE OF DIGITAL HEALTH, BIOMATERIALS

 

On January 11th, trailblazing medical technology company Xenco Medical unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum™ at the 2024 Consumer Electronics Show in Las Vegas, Nevada. Comprising the TrabeculeX Bioactive Matrix™ and the TrabeculeX Recovery App™, the TrabeculeX Continuum is the first technology-enabled bridge between orthobiologics and digital health, unifying a patient’s biomaterial implantation and postoperative journey. (Graphic: Business Wire)

KUALA LUMPUR, Jan 17 (Bernama) -- Trailblazing medical technology company, Xenco Medical recently unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum at the 2024 Consumer Electronics Show (CES) in Las Vegas.

Comprising the FDA-cleared TrabeculeX Bioactive Matrix and the TrabeculeX Recovery App, the TrabeculeX Continuum is the first technology-enabled bridge between orthobiologics and digital health, unifying a patient’s biomaterial implantation and postoperative journey.

“As a surgical technology company devoted not only to our patients' intraoperative care but to their longitudinal recovery, we have committed ourselves to dissolving the barriers that currently exist in the siloed path from surgery to rehabilitation.

“With the TrabeculeX Continuum, we are excited to introduce a connective technology that recognises the full arc of a patient’s journey rather than a single instance of care,” said Xenco Medical Founder and Chief Executive Officer, Jason Haider in a statement.

Engineered to harness the hydroxycarbonate apatite-forming capabilities of bioglass in every TrabeculeX Bioactive Matrix, the regenerative biomaterial included in the TrabeculeX Continuum has been intricately designed by Xenco Medical to conduct three-dimensional bone-formation.

Leveraging a complex surface topography, the TrabeculeX Bioactive Matrix’s novel architecture begins at the sub-micron scale and spans to the entire lattice itself.

Bridging the journey from biomaterial implantation to full physical rehabilitation, the TrabeculeX Recovery App enables surgeons who have used a TrabeculeX Bioactive Matrix strip in their patient to prescribe and remotely monitor patient-specific physical rehabilitation plans with the ability to engage in asynchronous video and text messaging.

-- BERNAMA